168 |
Non-LM Bifurcation Revascularization 2022: Guidelines and Concept Change |
Seung-Jung Park |
Nov. 02. 22 |
167 |
Provisional Side Branch Stenting: The Big Misunderstanding |
Thierry Lefevre |
Apr. 12. 21 |
166 |
Bifurcation PCI Optimization Using Intracoronary Guidance: Optimization Criteria and Supporting Clinical Data |
Myeong-Ki Hong |
Apr. 12. 21 |
165 |
2021 Clinical Data and Consensus Documents Updates on Bifurcation PCI Techniques: What Are New? |
Adrian P. Banning |
Apr. 12. 21 |
164 |
Upfront 2-Stenting for Bifurcation Lesions: When and How? |
Shaoliang Chen |
Apr. 12. 21 |
163 |
Bifurcation PCI at the Crossroads: New Physiology-Guided Decision-Making 2021 |
Bon-Kwon Koo |
Apr. 12. 21 |
162 |
The Most Important Things That We Have Learned from Syntax and Excel |
Thierry Lefevre |
Apr. 12. 21 |
161 |
Long-term(10-Year) Validation of the SYNTAX-II 2020 Score |
Patrick W. Serruys |
Aug. 06. 20 |
160 |
EXCEL Trial: Extended Long-term and Key Clinical Substudies |
Gregg W. Stone |
Aug. 06. 20 |
159 |
My Challenging Bifurcation PCI Case of the Year |
Thierry Lefevre |
Aug. 06. 20 |